Durable outcomes with manageable safety leading to prolonged survival with tagraxofusp for treatment-naïve patients with blastic plasmacytoid dendritic cell neoplasm: real world results from a European Named Patient Program
在未接受过治疗的浆细胞样树突状细胞肿瘤患者中，tagraxofusp 可带来持久疗效和可控的安全性，从而延长生存期：一项欧洲指定患者计划的真实世界结果
期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-025-06493-w
Herling, Marco; Angelucci, Emanuele; Benoit, Tobias Matthieu; Rivoli, Giulia; Curti, Antonio; Götze, Katharina S; Wirths, Stefan; Erakli, Dimoula; Zuurman, Michael; Deconinck, Eric
肿瘤
肿瘤免疫
树突状细胞
细胞生物学
树突状细胞
免疫/内分泌
